ARCHIVES

About Face; NCI To Keep Preclinical AIDS Drug Development

This article is from The Cancer Letter archive.

Vol. 12 No. 48 | December 12, 1986

Download PDF Visit The Full Archive

Related Articles

Studies Seek to Identify High-Risk Groups to Justify Mammography Screening at 40

May 4, 2012

NIH Grants: NIH Can’t Award Funds To Schools That Prevent Military Recruiting

September 12, 1997

Cancer Groups Propose Six Characteristics Of Next FDA Head.

December 19, 2008

Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival

January 31, 2014

Remaining DCT Recompetitions

November 7, 1980

NCI To Evaluate Chernobyl Effects On Soviet Health

November 23, 1990